首页 | 本学科首页   官方微博 | 高级检索  
     

地氯雷他啶与咪唑斯汀治疗慢性特发性荨麻疹的成本-效果分析
引用本文:梁强,刘恩让,谢倩. 地氯雷他啶与咪唑斯汀治疗慢性特发性荨麻疹的成本-效果分析[J]. 中国药房, 2006, 17(10): 755-756
作者姓名:梁强  刘恩让  谢倩
作者单位:深圳市第二人民医院,深圳市,518035
摘    要:目的:评价地氯雷他啶与咪唑斯汀治疗慢性特发性荨麻疹的成本-效果。方法:67例慢性特发性荨麻疹患者随机分为治疗组与对照组,分别给予地氯雷他啶、咪唑斯汀治疗14d,观察疗效并进行成本-效果分析。结果:治疗组与对照组的有效率分别为85.71%、87.10%(P>0.05);成本-效果比分别为0.456、0.622,对照组相对于治疗组的增量成本-效果比为15.9。结论:地氯雷他啶治疗慢性特发性荨麻疹相对于咪唑斯汀具有明显的药物经济学优势。

关 键 词:慢性特发性荨麻疹  地氯雷他啶  咪唑斯汀  成本-效果分析
文章编号:1001-0408(2006)10-0755-02
收稿时间:2006-02-28
修稿时间:2006-03-21

Cost - Effectiveness Analysis of Desloratadine and Mizolastine in Treatment of Chronic Idiopathic Urticaria
LIANG Qiang,LIU Enrang,XIE Qian. Cost - Effectiveness Analysis of Desloratadine and Mizolastine in Treatment of Chronic Idiopathic Urticaria[J]. China Pharmacy, 2006, 17(10): 755-756
Authors:LIANG Qiang  LIU Enrang  XIE Qian
Abstract:OBJECTIVE:To evaluate the cost-effectiveness of desloratadine and mizolastine in the treatment of chronic idiopathic urticaria.METHODS:67patients with chronic idiopathic urticaria were randomized into treatment group and control group,administered with desloratadine and mizolastine for14d,respectively.The curative effects were observed and cost-effectiveness analysis was made.RESULTS:The effective rates in the treatment and control group were85.71%and87.10%,respectively(P>0.05).The C/E were0.456and0.622,respectively.ΔC/ΔE was15.9.CONCLUSIONS:Deslo-ratadine has pharmacoeconomical advantages over mizolastine in treating chronic idiopathic urticaria.
Keywords:Chronic idiopathic urticaria    Desloratadine    Mizoslatine    Cost - effectiveness analysis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号